Turna Ray

A neurologist orders the wrong genetic test for a patient experiencing peripheral neuropathy and doesn't realize it even upon seeing the report.

A 31-year-old woman with stage IV breast cancer learns a test ordered more than a year before her diagnosis detected a TP53 mutation but she wasn't told.

Researchers analyzed molecular and particulate matter exposure data on nearly 9,000 NSCLC patients in France and confirmed a link reported by UK scientists in 2022.

Using Herceptin as an example, Andre Ilbawi detailed the challenges low- and medium-income countries face in accessing essential therapies.

A physician orders targeted HEXA sequencing when full sequencing is warranted during a high-risk couple's preconception screening, leading to dire consequences.

Data presented at ASCO found that only a dozen out of 800 patients with NTRK-altered advanced solid tumors got Vitrakvi or Rozlytrek over a two-year period.

A study drawing on germline genetic testing and claims data showed at ASCO that patients with VUS are, for the most part, managed like they have negative results.

In UK Biobank data, researchers found that clonal hematopoiesis of indeterminate potential exacerbates the impact of air pollution in non-smokers with lung cancer.

For the first three months of the year, the company's worldwide sales grew 9 percent to $15.78 billion and beat the consensus Wall Street revenue expectation.

At AACR's annual meeting, industry observers discussed how FDA's stance on RUOs amid its push to regulate LDTs is putting the "double squeeze" on the lab industry.